These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8969456)

  • 1. Production of highly homogeneous and structurally intact recombinant von Willebrand factor multimers by furin-mediated propeptide removal in vitro.
    Schlokat U; Fischer BE; Herlitschka S; Antoine G; Preininger A; Mohr G; Himmelspach M; Kistner O; Falkner FG; Dorner F
    Biotechnol Appl Biochem; 1996 Dec; 24(3):257-67. PubMed ID: 8969456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin.
    Fischer BE; Schlokat U; Mitterer A; Reiter M; Mundt W; Turecek PL; Schwarz HP; Dorner F
    FEBS Lett; 1995 Nov; 375(3):259-62. PubMed ID: 7498512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for recombinant Furin employment in a biotechnological process: complete target protein precursor cleavage.
    Preininger A; Schlokat U; Mohr G; Himmelspach M; Stichler V; Kyd-Rebenburg A; Plaimauer B; Turecek PL; Schwarz HP; Wernhart W; Fischer BE; Dorner F
    Cytotechnology; 1999 Jul; 30(1-3):1-16. PubMed ID: 19003349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a plasma- and albumin-free recombinant von Willebrand factor.
    Turecek PL; Mitterer A; Matthiessen HP; Gritsch H; Varadi K; Siekmann J; Schnecker K; Plaimauer B; Kaliwoda M; Purtscher M; Woehrer W; Mundt W; Muchitsch EM; Suiter T; Ewenstein B; Ehrlich HJ; Schwarz HP
    Hamostaseologie; 2009 Oct; 29 Suppl 1():S32-8. PubMed ID: 19763356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and function of a recombinant von Willebrand factor drug candidate.
    Turecek PL; Schrenk G; Rottensteiner H; Varadi K; Bevers E; Lenting P; Ilk N; Sleytr UB; Ehrlich HJ; Schwarz HP
    Semin Thromb Hemost; 2010 Jul; 36(5):510-21. PubMed ID: 20635317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease.
    Gritsch H; Schrenk G; Weinhappl N; Mellgård B; Ewenstein B; Turecek PL
    J Blood Med; 2022; 13():649-662. PubMed ID: 36405429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human factor X: high yield expression and the role of furin in proteolytic maturation in vivo and in vitro.
    Himmelspach M; Pfleiderer M; Fischer BE; Plaimauer B; Antoine G; Falkner FG; Dorner F; Schlokat U
    Thromb Res; 2000 Jan; 97(2):51-67. PubMed ID: 10688334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease.
    Schwarz HP; Dorner F; Mitterer A; Mundt W; Schlokat U; Pichler L; Turecek PL
    Wien Klin Wochenschr; 1999 Mar; 111(5):181-91. PubMed ID: 10226348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of recombinant proteins in Chinese hamster ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin.
    Ayoubi TA; Meulemans SM; Roebroek AJ; Van de Ven WJ
    Mol Biol Rep; 1996; 23(2):87-95. PubMed ID: 8983022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.
    Pekrul I; Kragh T; Turecek PL; Novack AR; Ott HW; Spannagl M
    Platelets; 2019; 30(2):264-270. PubMed ID: 29319374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease.
    Schwarz HP; Dorner F; Mitterer A; Mundt W; Schlokat U; Pichler L; Turecek PL
    Haemophilia; 1998; 4 Suppl 3():53-62. PubMed ID: 10028320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-mediated in vitro processing of pro-von Willebrand factor.
    Váradi K; Turecek PL; Mitterer A; Dorner F; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1449-58. PubMed ID: 11776313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
    Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
    Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant von Willebrand factor: preclinical development.
    Plaimauer B; Schlokat U; Turecek PL; Mitterer A; Mundt W; Auer W; Pichler L; Gritsch H; Schwarz HP
    Semin Thromb Hemost; 2001 Aug; 27(4):395-403. PubMed ID: 11547362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor.
    Kemptner J; Marchetti-Deschmann M; Müller R; Ivens A; Turecek P; Schwarz HP; Allmaier G
    Rapid Commun Mass Spectrom; 2010 Mar; 24(6):761-7. PubMed ID: 20169558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of plasma-derived and recombinant von Willebrand factor by atomic force microscopy.
    Seyfried BK; Friedbacher G; Rottensteiner H; Schwarz HP; Ehrlich H; Allmaier G; Turecek PL
    Thromb Haemost; 2010 Sep; 104(3):523-30. PubMed ID: 20589314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
    Turecek PL; Váradi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
    Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired dimerization of von Willebrand factor subunit due to mutation A2801D in the CK domain results in a recessive type 2A subtype IID von Willebrand disease.
    Hommais A; Stépanian A; Fressinaud E; Mazurier C; Pouymayou K; Meyer D; Girma JP; Ribba AS
    Thromb Haemost; 2006 May; 95(5):776-81. PubMed ID: 16676067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.